Institutional investors hold a majority ownership of IMGN through the 87.42% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2015, these large investors purchased a net $4.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DANSKE BANK A/S (INVT MGMT) Bought 8.3 Thousand shares of ImmunoGen Inc
MIZUHO ALTERNATIVE INVESTMENTS L... Bought 1.0 Thousand shares of ImmunoGen Inc
TEACHER RETIREMENT SYSTEM OF TEX... Bought 716.00 shares of ImmunoGen Inc